The stock of Monsanto Company (NYSE:MON) is a huge mover today! About 519,769 shares traded hands. Monsanto Company (NYSE:MON) has risen 15.87% since March 8, 2016 and is uptrending. It has outperformed by 6.55% the S&P500.
The move comes after 8 months positive chart setup for the $44.73 billion company. It was reported on Oct, 11 by Barchart.com. We have $163.13 PT which if reached, will make NYSE:MON worth $26.39B more.
Monsanto Company (NYSE:MON) Ratings Coverage
Out of 20 analysts covering Monsanto Company (NYSE:MON), 14 rate it a “Buy”, 1 “Sell”, while 5 “Hold”. This means 70% are positive. Monsanto Company has been the topic of 39 analyst reports since August 25, 2015 according to StockzIntelligence Inc. The stock of Monsanto Company (NYSE:MON) earned “Neutral” rating by Atlantic Securities on Friday, May 27. The rating was maintained by UBS on Tuesday, June 14 with “Buy”. Barclays Capital maintained Monsanto Company (NYSE:MON) on Thursday, October 6 with “Equal-Weight” rating. UBS maintained the shares of MON in a report on Thursday, October 8 with “Buy” rating. On Thursday, August 27 the stock rating was maintained by Piper Jaffray with “Overweight”. Morgan Stanley reinitiated the stock with “Overweight” rating in Thursday, August 27 report. Deutsche Bank maintained it with “Buy” rating and $128 target price in Thursday, September 15 report. The stock of Monsanto Company (NYSE:MON) has “Underperform” rating given on Friday, September 11 by Bernstein. As per Wednesday, September 21, the company rating was upgraded by JP Morgan. The firm has “Underperform” rating given on Thursday, September 15 by CLSA.
According to Zacks Investment Research, “Monsanto is a leading global provider of technology-based solutions and agricultural products for growers and downstream customers, such as grain processors and consumers, in the agricultural markets. The combination of its herbicides, seeds and related genetic trait products provides growers with integrated solutions to more efficiently and cost effectively produce crops at higher yields, while controlling weeds, insects and diseases. Its base business, led by Roundup and coupled with the latest tools in biotechnology, genomics and molecular breeding.”
Insitutional Activity: The institutional sentiment increased to 0.91 in 2016 Q2. Its up 0.10, from 0.81 in 2016Q1. The ratio improved, as 88 funds sold all Monsanto Company shares owned while 334 reduced positions. 142 funds bought stakes while 243 increased positions. They now own 338.57 million shares or 4.89% less from 355.97 million shares in 2016Q1.
Monetary Mngmt Group has 0.25% invested in the company for 5,178 shares. Fir Tree last reported 1.48% of its portfolio in the stock. Argent Mgmt Limited Liability Corporation last reported 2,000 shares in the company. Tradewinds Cap Mngmt Limited Company last reported 0.13% of its portfolio in the stock. Cibc World has invested 0% of its portfolio in Monsanto Company (NYSE:MON). Capstone Invest Advsrs Limited Liability Corp, a New York-based fund reported 9,383 shares. Pictet Asset Management has invested 0.14% of its portfolio in Monsanto Company (NYSE:MON). Tiaa Cref Inv Mngmt Ltd Co has 0.37% invested in the company for 4.66M shares. Dorsey & Whitney Limited Liability Co has 2,080 shares for 0.05% of their US portfolio. Moreover, Hightower Limited Liability Co has 0.06% invested in Monsanto Company (NYSE:MON) for 49,169 shares. Livingston Group Asset Mngmt Co (Operating As Southport Cap Management) accumulated 0.21% or 3,700 shares. Cls Invs Lc accumulated 51 shares or 0% of the stock. Fjarde Ap reported 102,331 shares or 0.25% of all its holdings. City Hldgs accumulated 206 shares or 0.01% of the stock. Herndon Cap Mgmt Ltd Liability, a Georgia-based fund reported 40 shares.
Insider Transactions: Since April 12, 2016, the stock had 0 insider purchases, and 1 sale for $104,428 net activity. Frank Michael J had sold 2,000 shares worth $174,984. MIZELL STEVEN sold 9,500 shares worth $846,070. MCMILLAN CHARLES S bought 3,500 shares worth $305,375. POSTE GEORGE sold 1,136 shares worth $104,428.
More notable recent Monsanto Company (NYSE:MON) news were published by: Investorplace.com which released: “Monsanto Company’s Headwinds Make MON Stock a Tough Buy” on October 11, 2016, also Seekingalpha.com with their article: “The Gem In Monsanto’s Earnings Announcement And How To Build On It” published on October 11, 2016, Businesswire.com published: “Monsanto and Dow AgroSciences Announce Global Licensing Agreement on EXZACT …” on October 03, 2016. More interesting news about Monsanto Company (NYSE:MON) were released by: Seekingalpha.com and their article: “The Investment Opportunity In Monsanto” published on October 07, 2016 as well as Businesswire.com‘s news article titled: “Monsanto Company Sets Webcast and Analyst/Media Call for Fourth Quarter and …” with publication date: September 28, 2016.
MON Company Profile
Monsanto Company (Monsanto), incorporated on February 9, 2000, along with its subsidiaries, is a well-known provider of agricultural products for farmers. The Firm provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Firm operates through two divisions: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.